Published in Gene Ther on March 03, 2011
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res (2013) 1.20
Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles. Mol Ther (2012) 1.07
Manufacturing of recombinant adeno-associated viral vectors for clinical trials. Mol Ther Methods Clin Dev (2016) 1.05
A Molecular Toolbox for Rapid Generation of Viral Vectors to Up- or Down-Regulate Neuronal Gene Expression in vivo. Front Mol Neurosci (2011) 1.04
Molecular dissection of human Argonaute proteins by DNA shuffling. Nat Struct Mol Biol (2013) 1.03
The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression. Silence (2011) 1.00
Gene therapy in animal models of autosomal dominant retinitis pigmentosa. Mol Vis (2012) 0.99
Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. Mol Ther (2013) 0.96
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction. Mol Ther (2015) 0.94
siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse. Nucleic Acids Res (2012) 0.93
Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa. Mol Ther (2015) 0.85
Studies of efficacy and liver toxicity related to adeno-associated virus-mediated RNA interference. Hum Gene Ther (2013) 0.82
Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors. Mol Ther Methods Clin Dev (2015) 0.81
Recent advances in RNA interference therapeutics for CNS diseases. Neurotherapeutics (2013) 0.81
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype. J Clin Invest (2016) 0.80
Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates. Hum Gene Ther (2016) 0.79
RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration. PLoS One (2014) 0.79
Lentiviral vector-mediated RNA silencing in the central nervous system. Hum Gene Ther Methods (2013) 0.79
Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism. Neurobiol Dis (2015) 0.79
The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy. Neuroscience (2012) 0.78
DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition. PLoS One (2012) 0.78
GHS-R1a signaling in the DMH and VMH contributes to food anticipatory activity. Int J Obes (Lond) (2013) 0.77
Viral delivery of shRNA to amygdala neurons leads to neurotoxicity and deficits in Pavlovian fear conditioning. Neurobiol Learn Mem (2015) 0.77
Early lethality of shRNA-transgenic pigs due to saturation of microRNA pathways. J Zhejiang Univ Sci B (2014) 0.77
Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis. J Neurosci (2016) 0.75
Caspase-3 and GFAP as early markers for apoptosis and astrogliosis in shRNA-induced hippocampal cytotoxicity. J Exp Biol (2017) 0.75
Sodium chloride enhances rAAV production in a serum-free suspension manufacturing platform using the Herpes Simplex Virus System. Hum Gene Ther Methods (2017) 0.75
Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome. Sci Rep (2016) 0.75
The Drosophila ETV5 Homologue Ets96B: Molecular Link between Obesity and Bipolar Disorder. PLoS Genet (2016) 0.75
Prospect of induced pluripotent stem cell genetic repair to cure genetic diseases. Stem Cells Int (2012) 0.75
Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin. Mol Ther Nucleic Acids (2017) 0.75
Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing. Mol Ther Methods Clin Dev (2017) 0.75
Gene suppression approaches to neurodegeneration. Alzheimers Res Ther (2017) 0.75
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature (2006) 10.95
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A (2000) 5.01
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci U S A (2005) 4.79
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A (2008) 4.53
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron (2005) 3.75
Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther (2008) 2.66
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol Ther (2005) 2.47
Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc Natl Acad Sci U S A (2008) 2.32
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther (2008) 2.01
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest (2010) 1.91
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol (2010) 1.62
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci (2005) 1.53
Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neurosci (2010) 1.33
Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol (2004) 1.15
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15
DNA constructs designed to produce short hairpin, interfering RNAs in transgenic mice sometimes show early lethality and an interferon response. J Appl Genet (2005) 1.07
DARPP-32 genomic fragments drive Cre expression in postnatal striatum. Genesis (2005) 1.07
Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann Neurol (2003) 1.00
Technology insight: therapeutic RNA interference--how far from the neurology clinic? Nat Clin Pract Neurol (2007) 0.99
The inherited dystonias. Semin Neurol (2007) 0.92
RNAi blocks DYT1 mutant torsinA inclusions in neurons. Neurosci Lett (2005) 0.85
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry (1983) 8.71
Interventions for preventing obesity in children. Cochrane Database Syst Rev (2005) 7.48
The population genetic consequences of habitat fragmentation for plants. Trends Ecol Evol (1996) 6.87
The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Infect (2004) 6.85
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol (1988) 5.18
Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect (2004) 4.54
Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med (1990) 4.21
Intrauterine parvovirus infection associated with hydrops fetalis. Lancet (1984) 3.99
Detection of PCR products using self-probing amplicons and fluorescence. Nat Biotechnol (1999) 3.94
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol (2000) 3.77
Structure of an adenine-cytosine base pair in DNA and its implications for mismatch repair. Nature (1986) 3.00
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg (2000) 2.88
Bayesian melding for estimating uncertainty in national HIV prevalence estimates. Sex Transm Infect (2008) 2.67
High-resolution structure of a DNA helix containing mismatched base pairs. Nature (1985) 2.56
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature (1995) 2.49
Molecular structure of the G.A base pair in DNA and its implications for the mechanism of transversion mutations. Proc Natl Acad Sci U S A (1986) 2.46
Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci U S A (1990) 2.41
Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology (2007) 2.40
The burden of cancer at work: estimation as the first step to prevention. Occup Environ Med (2007) 2.29
Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med (1987) 2.23
Crystal structure of a G:T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell (1998) 2.20
Kepler's optical phase curve of the exoplanet HAT-P-7b. Science (2009) 2.18
Mode of action and application of Scorpion primers to mutation detection. Nucleic Acids Res (2000) 2.07
The crystal structure of d(G-G-G-G-C-C-C-C). A model for poly(dG).poly(dC). J Mol Biol (1985) 2.03
Crystal structure of a DNA duplex containing 8-hydroxydeoxyguanine-adenine base pairs. Biochemistry (1994) 2.01
Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect (2006) 1.90
Constitutive synthesis of tumor necrosis factor in the thymus. Proc Natl Acad Sci U S A (1992) 1.89
Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl Med Biol (1995) 1.88
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77
Articular fractures: does an anatomic reduction really change the result? J Bone Joint Surg Am (2002) 1.74
The structure of guanosine-thymidine mismatches in B-DNA at 2.5-A resolution. J Biol Chem (1987) 1.72
Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol (2001) 1.72
Surveillance and modelling of HIV, STI, and risk behaviours in concentrated HIV epidemics. Sex Transm Infect (2004) 1.69
Crystal structure of a thwarted mismatch glycosylase DNA repair complex. EMBO J (1999) 1.62
Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS (1999) 1.61
Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol (1999) 1.60
Mechanoreception at the cellular level: the detection, interpretation, and diversity of responses to mechanical signals. Biochem Cell Biol (1996) 1.51
Comparison of the thermodynamic stabilities and solution conformations of DNA.RNA hybrids containing purine-rich and pyrimidine-rich strands with DNA and RNA duplexes. Biochemistry (1996) 1.49
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines. J Clin Invest (1991) 1.48
Jugular venous bulb catheterization in infants and children. Crit Care Med (1989) 1.47
Mortality and cancer incidence among British agricultural pesticide users. Occup Med (Lond) (2011) 1.45
Chiral phosphorothioate analogues of B-DNA. The crystal structure of Rp-d[Gp(S)CpGp(S)CpGp(S)C]. J Mol Biol (1986) 1.43
The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA. Nature (1986) 1.43
Sheep linkage mapping: nineteen linkage groups derived from the analysis of paternal half-sib families. Genetics (1994) 1.43
Crystal structure of an octameric RuvA-Holliday junction complex. Mol Cell (1998) 1.42
Reduction of Lyme disease exposure by recognition and avoidance of high-risk areas. Lancet (1997) 1.40
Inosine.adenine base pairs in a B-DNA duplex. Nucleic Acids Res (1987) 1.40
The treatment of facial disharmony and malocclusion by jaw surgery. Case reports. Aust Dent J (1991) 1.39
High-resolution structure of a mutagenic lesion in DNA. Proc Natl Acad Sci U S A (1990) 1.38
Solution structures of DNA.RNA hybrids with purine-rich and pyrimidine-rich strands: comparison with the homologous DNA and RNA duplexes. Biochemistry (1998) 1.37
G . T base-pairs in a DNA helix: the crystal structure of d(G-G-G-G-T-C-C-C). J Mol Biol (1985) 1.36
Refined crystal structure of an octanucleotide duplex with I.T. mismatched base pairs. Nucleic Acids Res (1989) 1.35
Focusing of high numerical aperture cylindrical-vector beams. Opt Express (2000) 1.35
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndrome. J Infect Dis (1996) 1.33
Crystal and molecular structure of r(CGCGAAUUAGCG): an RNA duplex containing two G(anti).A(anti) base pairs. Structure (1994) 1.33
The contribution of cytosine protonation to the stability of parallel DNA triple helices. J Mol Biol (1998) 1.33
Routine application of the nitroblue tetrazolium test in the clinical laboratory. J Clin Pathol (1973) 1.30
Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res (2001) 1.29
CNQX increases spontaneous inhibitory input to CA3 pyramidal neurones in neonatal rat hippocampal slices. Brain Res (1992) 1.29
Sequence analysis of the lpdV gene for lipoamide dehydrogenase of branched-chain-oxoacid dehydrogenase of Pseudomonas putida. Eur J Biochem (1989) 1.28
Skeletal ossification and the adolescent growth spurt. Am J Orthod (1976) 1.28
Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci (1999) 1.27
Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J (1990) 1.26
Observations by immunofluorescence microscopy and electron microscopy on the cytopathogenicity of Naegleria fowleri in mouse embryo-cell cultures. J Med Microbiol (1979) 1.25
Refined crystal structure of an octanucleotide duplex with G . T mismatched base-pairs. J Mol Biol (1986) 1.24
Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24
HIV and AIDS in the Asia-Pacific region: an epidemiological overview. AIDS (1998) 1.24
Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1998) 1.22
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet (1987) 1.22
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest (1992) 1.22
Structural features and hydration of d(C-G-C-G-A-A-T-T-A-G-C-G); a double helix containing two G.A mispairs. J Biomol Struct Dyn (1986) 1.21
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
NMR assignments and solution conformation of the DNA.RNA hybrid duplex d(GTGAACTT).r(AAGUUCAC). Eur J Biochem (1993) 1.20
The role of a physical fitness program in the treatment of alcoholism. J Stud Alcohol (1982) 1.20
Affinity of mismatch-binding protein MutS for heteroduplexes containing different mismatches. Biochem J (2001) 1.20
Structural and thermodynamic studies on the adenine.guanine mismatch in B-DNA. Nucleic Acids Res (1990) 1.20
Comparison of the electrophoretic and hydrodynamic properties of DNA and RNA oligonucleotide duplexes. Biophys J (1997) 1.17
Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol (2000) 1.17
Mortality from infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitisers. Thorax (2009) 1.14
Structural features and hydration of a dodecamer duplex containing two C.A mispairs. Nucleic Acids Res (1987) 1.13
5-(1-propargylamino)-2'-deoxyuridine (UP): a novel thymidine analogue for generating DNA triplexes with increased stability. Nucleic Acids Res (1999) 1.12
Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology (2000) 1.12
Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet (1998) 1.11
Interaction of berenil with the EcoRI dodecamer d(CGCGAATTCGCG)2 in solution studied by NMR. Biochemistry (1991) 1.10
Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides. Biochem Biophys Res Commun (1995) 1.10
The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS (1997) 1.10
Consequences of the DYT1 mutation on torsinA oligomerization and degradation. Neuroscience (2008) 1.10
PDGF-BB, IGF-I and mechanical load stimulate DNA synthesis in avian tendon fibroblasts in vitro. J Biomech (1995) 1.09
Granulomatous disease associated with Bartonella infection in 2 dogs. J Vet Intern Med (2000) 1.09
Severe delayed hemolytic transfusion reaction secondary to anti-At(a). Transfusion (1999) 1.09
Molecular typing of avian Escherichia coli isolates by random amplification of polymorphic DNA. Avian Dis (1998) 1.09
Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups. Nucleic Acids Res (1992) 1.09
Solution conformation of a deoxynucleotide containing tandem G.A mismatched base pairs and 3'-overhanging ends in d(GTGAACTT)2. Biochemistry (1992) 1.09
Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol (1988) 1.09
Comparison of the amino acid sequences of the transacylase components of branched chain oxoacid dehydrogenase of Pseudomonas putida, and the pyruvate and 2-oxoglutarate dehydrogenases of Escherichia coli. Eur J Biochem (1988) 1.08
Barnase has subsites that give rise to large rate enhancements. Biochemistry (1992) 1.07